Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Alpert

Showing results (341-350 of 377) with videos related to

Pageof 38
Sort By:
The American Journal of Psychiatry|April 19, 2023
Structural Racism in Psychiatric Research Careers: Eradicating Barriers to a More Diverse WorkforceAlik S Widge, Ayana Jordan, Nina V Kraguljac, et al.
Frontiers in Psychiatry|January 4, 2021
Monitoring Changes in Depression Severity Using Wearable and Mobile SensorsPaola Pedrelli, Szymon Fedor, Asma Ghandeharioun, et al.
The American Journal of Psychiatry|January 28, 2026
The Future of <i>DSM</i>: Are Functioning and Quality of Life Essential Elements of a Complete Psychiatric Diagnosis?Karen Drexler, Jonathan E Alpert, Tami D Benton, et al.
Psychiatric Services (Washington, D.C.)|March 12, 2026
Characteristics of Studies on the Diagnosis of Malingering: A Systematic ReviewKevin Y Xu, Tashalee R Brown, Adrienne Grzenda, et al.
The American Journal of Psychiatry|January 28, 2026
The Future of <i>DSM</i>: A Strategic Vision for Incorporating Socioeconomic, Cultural, and Environmental Determinants and IntersectionalityMilton L Wainberg, Jonathan E Alpert, Tami D Benton, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 10, 2008
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorderDavid Mischoulon, Catherine Best-Popescu, Michael Laposata, et al.
American Journal of Preventive Medicine|March 17, 2009
Obesity among those with mental disorders: a National Institute of Mental Health meeting reportDavid B Allison, John W Newcomer, Andrea L Dunn, et al.
The Journal of Clinical Psychiatry|August 28, 2009
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorderDavid Mischoulon, George I Papakostas, Christina M Dording, et al.
Journal of Consulting and Clinical Psychology|September 6, 2022
Digital bibliotherapy as a scalable intervention for suicidal thoughts: A randomized controlled trialPeter J Franz, David Mou, Daniel T Kessler, et al.
The American Journal of Psychiatry|July 4, 2006
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D reportMaurizio Fava, A John Rush, Stephen R Wisniewski, et al.
Pageof 38

Showing results (341-350 of 377) with videos related to

Sort By:
Pageof 38
The American Journal of Psychiatry|April 19, 2023
Structural Racism in Psychiatric Research Careers: Eradicating Barriers to a More Diverse WorkforceAlik S Widge, Ayana Jordan, Nina V Kraguljac, et al.
Frontiers in Psychiatry|January 4, 2021
Monitoring Changes in Depression Severity Using Wearable and Mobile SensorsPaola Pedrelli, Szymon Fedor, Asma Ghandeharioun, et al.
The American Journal of Psychiatry|January 28, 2026
The Future of <i>DSM</i>: Are Functioning and Quality of Life Essential Elements of a Complete Psychiatric Diagnosis?Karen Drexler, Jonathan E Alpert, Tami D Benton, et al.
Psychiatric Services (Washington, D.C.)|March 12, 2026
Characteristics of Studies on the Diagnosis of Malingering: A Systematic ReviewKevin Y Xu, Tashalee R Brown, Adrienne Grzenda, et al.
The American Journal of Psychiatry|January 28, 2026
The Future of <i>DSM</i>: A Strategic Vision for Incorporating Socioeconomic, Cultural, and Environmental Determinants and IntersectionalityMilton L Wainberg, Jonathan E Alpert, Tami D Benton, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 10, 2008
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorderDavid Mischoulon, Catherine Best-Popescu, Michael Laposata, et al.
American Journal of Preventive Medicine|March 17, 2009
Obesity among those with mental disorders: a National Institute of Mental Health meeting reportDavid B Allison, John W Newcomer, Andrea L Dunn, et al.
The Journal of Clinical Psychiatry|August 28, 2009
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorderDavid Mischoulon, George I Papakostas, Christina M Dording, et al.
Journal of Consulting and Clinical Psychology|September 6, 2022
Digital bibliotherapy as a scalable intervention for suicidal thoughts: A randomized controlled trialPeter J Franz, David Mou, Daniel T Kessler, et al.
The American Journal of Psychiatry|July 4, 2006
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D reportMaurizio Fava, A John Rush, Stephen R Wisniewski, et al.
Pageof 38